55 related articles for article (PubMed ID: 7868940)
21. Characterization of pituitary calcium-activated, phospholipid-dependent protein kinase: redistribution by gonadotropin-releasing hormone.
Naor Z; Zer J; Zakut H; Hermon J
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8203-7. PubMed ID: 3906659
[TBL] [Abstract][Full Text] [Related]
22. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Cuttitta F; Carney DN; Mulshine J; Moody TW; Fedorko J; Fischler A; Minna JD
Nature; 1985 Aug 29-Sep 4; 316(6031):823-6. PubMed ID: 2993906
[TBL] [Abstract][Full Text] [Related]
23. Membrane receptors for peptides in experimental and human pancreatic cancers.
Fekete M; Zalatnai A; Comaru-Schally AM; Schally AV
Pancreas; 1989; 4(5):521-8. PubMed ID: 2573055
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
Liebow C; Reilly C; Serrano M; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
[TBL] [Abstract][Full Text] [Related]
25. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
Szende B; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of the trophic actions of bombesin on the pancreas.
Upp JR; Poston GJ; MacLellan DG; Townsend CM; Barranco SC; Thompson JC
Pancreas; 1988; 3(2):193-8. PubMed ID: 2453876
[TBL] [Abstract][Full Text] [Related]
27. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
28. Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early postnatal period.
Lehy T; Puccio F
Regul Pept; 1990 Jan; 27(1):87-96. PubMed ID: 2408114
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction mechanisms of Ca2+ mobilizing hormones: the case of gonadotropin-releasing hormone.
Naor Z
Endocr Rev; 1990 May; 11(2):326-53. PubMed ID: 2194785
[TBL] [Abstract][Full Text] [Related]
30. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor and bombesin differ strikingly in the induction of early responses in Swiss 3T3 cells.
Bierman AJ; Koenderman L; Tool AJ; De Laat SW
J Cell Physiol; 1990 Mar; 142(3):441-8. PubMed ID: 2155909
[TBL] [Abstract][Full Text] [Related]
32. Cancer statistics, 1991.
Boring CC; Squires TS; Tong T
CA Cancer J Clin; 1991; 41(1):19-36. PubMed ID: 1984806
[No Abstract] [Full Text] [Related]
33. Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies.
Schally AV; Srkalovic G; Szende B; Redding TW; Janaky T; Juhasz A; Korkut E; Cai RZ; Szepeshazi K; Radulovic S
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1061-7. PubMed ID: 1981009
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.
Szende B; Srkalovic G; Schally AV; Lapis K; Groot K
Cancer; 1990 May; 65(10):2279-90. PubMed ID: 1971771
[TBL] [Abstract][Full Text] [Related]
35. Biology of pancreatic cancer.
Poston GJ; Gillespie J; Guillou PJ
Gut; 1991 Jul; 32(7):800-12. PubMed ID: 1855689
[TBL] [Abstract][Full Text] [Related]
36. Hormones and pancreatic cancer.
Longnecker DS
Int J Pancreatol; 1991; 9():81-6. PubMed ID: 1744451
[TBL] [Abstract][Full Text] [Related]
37. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
39. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
Lee MT; Liebow C; Kamer AR; Schally AV
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1656-60. PubMed ID: 1672042
[TBL] [Abstract][Full Text] [Related]
40. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT
Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
